Grand Rounds Presentations

Andrea Jakubowski, MD, MS | April 8, 2025: Over two decades into the opioid overdose crisis, buprenorphine remains underutilized and inaccessible to many people with opioid use disorder. Improving accessibility and utilization requires attention to where treatment is offered and how patients are treated once they enter care. In this presentation, Dr. Jakubowski will describe:…

Tanya Saraiya, PhD | April 22, 2025: Up to 90% of people with opioid use disorder (OUD) have trauma exposure and up to 41% have posttraumatic stress disorder (PTSD). However, studies estimate that less than 12% of people with OUD and co-occurring PTSD receive treatment for their PTSD. Dr. Saraiya will present her early career…

Theresa Matson, PhD, MPH | March 11, 2025: Understanding why some interventions succeed while others fail is crucial for implementing evidence-based practices in real-world settings. Implementation efforts are complex, involving many factors, including the intervention itself, the strategies used to put it into practice, and the unique characteristics of each setting. Traditional research methods provide…

Beth Rutkowski, MPH and Thomas Freese, PhD | March 4, 2025 : Recent evidence indicates that methamphetamine and cocaine play a substantial and increasing role in the illicit drug crisis in the US—the 4th wave of the overdose crisis. The behavioral treatment known as contingency management (CM) has more than three decades of robust research supporting…

Kelli Scott, PhD | February 25, 2025 : Measurement-based care (MBC) involves the systematic evaluation of client treatment progress and the use of progress data to inform treatment planning. Although MBC is an evidence-based practice that has been widely studied in behavioral health settings, there is a dearth of research exploring its potential to monitor…

Rachel Shelton, ScD, MPH and Nathalie Moise, MD, MS | February 11, 2025 : There is a need and opportunity to advance the science of de-implementation. Mammography screening among women 75 and older presents a robust area for inquiry related to de-implementation, as routine screening can lead to potential harms (e.g., overdiagnosis, overtreatment) while health benefits…

JD Smith, PhD and James Merle, PhD | February 18, 2025 : Documenting and tracking the dynamic changes to implementation strategies over time is crucial for advancing implementation science. Several methods for tracking strategies have been proposed recently, underscoring the importance of continued development of methods to accurately assess and monitor which strategies are used,…

Beth Meyerson, MDiv, PhD | February 4, 2025 : Methadone Patient Access to Collaborative Treatment (MPACT) is an experimental, multimodal intervention for methadone clinic staff and funded by NIDA. This presentation will provide a brief overview of MPACT, discuss the planned hybrid trial (late fall 2025), the village that collaboratively developed MPACT and the importance…

Berkeley Franz, PhD | January 28, 2025: Buprenorphine is a critical tool to prevent overdose and infectious disease transmission in people with opioid use disorder, but it is difficult to access in rural areas. A promising solution is to engage rural primary care professionals. But the willingness of primary care professionals to prescribe this medication presents…

Ginger McKay, PhD | January 21, 2025 : Given the progress of implementation research to address the HIV epidemic in the US, criteria specifically for evaluating the quality of implementation research and strategy effectiveness are needed to recommend strategies likely to have impact for practitioners. We will describe the development and application of the Best…